Contact
searchSearch
HMP Global

Crohn's Disease Excellence Forum

Crohn's Disease
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Shirley Cohen Mekelburg
Conference Coverage
Shirley Cohen-Mekelburg, MD, on Penetrating and Stricturing Crohn's Disease
08/25/2025
Dr Cohen-Mekelburg recaps the key takeaways from her presentation at the AIBD regional meeting in Detroit on managing penetrating and stricturing Crohn's disease and perianal disease.
Dr Cohen-Mekelburg recaps the key takeaways from her presentation at the AIBD regional meeting in Detroit on managing penetrating and stricturing Crohn's disease and perianal disease.
Dr Cohen-Mekelburg recaps the...
08/25/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
Anita Afzali, MD, on the ACG Guidelines for Crohn's Disease
08/18/2025
Raymond Cross, MD; Anita Afzali
Dr Anita Afzali reviews with Dr Raymond Cross the updated guidelines for managing Crohn's disease from the American College of Gastroenterology,
Dr Anita Afzali reviews with Dr Raymond Cross the updated guidelines for managing Crohn's disease from the American College of Gastroenterology,
Dr Anita Afzali reviews with Dr...
08/18/2025
Advances in Inflammatory Bowel Disease Network
Tauseef Ali
Conference Coverage
Tauseef Ali, MD, on Penetrating and Stricturing Crohn's Disease
07/03/2025
Dr Ali recaps his presentation from the AIBD Dallas regional meeting on the treatment of penetrating and stricturing Crohn's disease.
Dr Ali recaps his presentation from the AIBD Dallas regional meeting on the treatment of penetrating and stricturing Crohn's disease.
Dr Ali recaps his presentation...
07/03/2025
Advances in Inflammatory Bowel Disease Network
Conference coverage
Miguel Regueiro, MD, on Updates in Postoperative Crohn's Disease
05/21/2025
Miguel D. Regueiro, MD
Dr Regueiro reviews three major abstracts from Cleveland Clinic presented at DDW 2025 on postoperative Crohn's disease, including biomarker monitoring, the effect of previous anti-TNF exposure, and biologic therapy for older patients.
Dr Regueiro reviews three major abstracts from Cleveland Clinic presented at DDW 2025 on postoperative Crohn's disease, including biomarker monitoring, the effect of previous anti-TNF exposure, and biologic therapy for older patients.
Dr Regueiro reviews three major...
05/21/2025
Advances in Inflammatory Bowel Disease Network
Miguel Regueiro MD
Conference coverage
Miguel Regueiro, MD, on Updates in Treatment of Perianal Crohn's Disease
05/12/2025
Miguel D. Regueiro, MD
Dr Regueiro reviews his presentation of the Patricia and Ralph Gianella lecture from DDW 2025 on the updates to the treatment algorithm for perianal Crohn's disease.
Dr Regueiro reviews his presentation of the Patricia and Ralph Gianella lecture from DDW 2025 on the updates to the treatment algorithm for perianal Crohn's disease.
Dr Regueiro reviews his...
05/12/2025
Advances in Inflammatory Bowel Disease Network
Ed Barnes
Conference coverage
Edward Barnes, MD, on Penetrating and Stricturing Crohn's Disease
05/09/2025
Edward L. Barnes
Dr Barnes reviews the key points of his presentation from the AIBD regional meeting on managing penetrating and stricturing complications of Crohn's disease.
Dr Barnes reviews the key points of his presentation from the AIBD regional meeting on managing penetrating and stricturing complications of Crohn's disease.
Dr Barnes reviews the key points...
05/09/2025
Advances in Inflammatory Bowel Disease Network
David Rubin
Video
David Rubin, MD, on the GALAXI 2 and 3 Trials of Guselkumab in Crohn's Disease
02/10/2025
Dr Rubin recaps his presentation from the ACG scientific meeting on the results of phase 3 trials of guselkumab for treatment of Crohn's disease among patients who are bionaive, bioexposed, and biointolerant or who failed to respond to...
Dr Rubin recaps his presentation from the ACG scientific meeting on the results of phase 3 trials of guselkumab for treatment of Crohn's disease among patients who are bionaive, bioexposed, and biointolerant or who failed to respond to...
Dr Rubin recaps his presentation...
02/10/2025
Advances in Inflammatory Bowel Disease Network
Marla Dubinsky
Conference coverage
Marla Dubinsky, MD, on Risk Stratification in Crohn's Disease
01/16/2025
Dr Dubinsky opened the 2024 Advances in Inflammatory Bowel Disease conference with a firm statement that virtually all patients with Crohn's disease should be treated quickly after diagnosis with approved and effective therapies to help...
Dr Dubinsky opened the 2024 Advances in Inflammatory Bowel Disease conference with a firm statement that virtually all patients with Crohn's disease should be treated quickly after diagnosis with approved and effective therapies to help...
Dr Dubinsky opened the 2024...
01/16/2025
Advances in Inflammatory Bowel Disease Network
Ed Loftus
Clinical Pearls
Edward Loftus, MD, on Upper GI Crohn's Disease
01/07/2025
Edward V. Loftus, Jr., MD
Dr Loftus explains how Crohn's disease can affect the upper gastrointestinal system, from the mouth to the duodenum, and the options for treating this rare presentation.
Dr Loftus explains how Crohn's disease can affect the upper gastrointestinal system, from the mouth to the duodenum, and the options for treating this rare presentation.
Dr Loftus explains how Crohn's...
01/07/2025
Advances in Inflammatory Bowel Disease Network
Miguel Regueiro MD
Conference coverage
Miguel Regueiro, MD, on Complex Crohn's Disease
12/11/2024
Dr Regueiro recaps his address at the AIBD annual meeting on complex Crohn's disease, focusing on intra-abdominal and perianal abscesses and stricturing, and the best therapies for each including both medical and surgical options.
Dr Regueiro recaps his address at the AIBD annual meeting on complex Crohn's disease, focusing on intra-abdominal and perianal abscesses and stricturing, and the best therapies for each including both medical and surgical options.
Dr Regueiro recaps his address...
12/11/2024
Advances in Inflammatory Bowel Disease Network

Latest News

Research Highlights
Concomitant Medications Do Not Alter Efficacy of Advanced Therapies in Ulcerative Colitis, Study Finds
09/18/2025
Jessica Garlewicz
New study findings suggest that most baseline concomitant therapies do not require modification or exclusion when initiating advanced therapy in clinical trial settings.
New study findings suggest that most baseline concomitant therapies do not require modification or exclusion when initiating advanced therapy in clinical trial settings.
New study findings suggest that...
09/18/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Persistent Prothrombotic State Observed in Patients With ASUC
09/04/2025
Rebecca Mashaw
New findings show patients with acute severe ulcerative colitis remain at elevated thrombotic risk for up to 12 weeks post-hospitalization.
New findings show patients with acute severe ulcerative colitis remain at elevated thrombotic risk for up to 12 weeks post-hospitalization.
New findings show patients with...
09/04/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Upadacitinib Improves Outcomes in Fistulizing Crohn’s Disease
09/04/2025
Rebecca Mashaw
Patients with fistulizing Crohn’s disease achieved higher rates of fistula resolution and clinical response with upadacitinib versus placebo.
Patients with fistulizing Crohn’s disease achieved higher rates of fistula resolution and clinical response with upadacitinib versus placebo.
Patients with fistulizing...
09/04/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Pelvic MRI Detects Subclinical Perianal Disease in Pediatric Crohn’s Disease
09/04/2025
Jessica Garlewicz
The study highlights a diagnostic blind spot in pediatric CD management and supports adding baseline pelvic MRI to initial workup, even in the absence of perianal symptoms.
The study highlights a diagnostic blind spot in pediatric CD management and supports adding baseline pelvic MRI to initial workup, even in the absence of perianal symptoms.
The study highlights a...
09/04/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Mirikizumab Improves Quality of Life and Work Productivity in Moderate to Severe Crohn’s Disease
09/04/2025
Jessica Garlewicz
Study findings highlight mirikizumab as a therapeutic option that delivers not only symptom relief but also sustained improvements in quality of life and functional outcomes for patients with moderate to severe CD.
Study findings highlight mirikizumab as a therapeutic option that delivers not only symptom relief but also sustained improvements in quality of life and functional outcomes for patients with moderate to severe CD.
Study findings highlight...
09/04/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Risankizumab Improves Symptom Resolution and Quality of Life in Ulcerative Colitis
09/04/2025
Jessica Garlewicz
Risankizumab led to earlier and sustained improvements in individual symptoms—including abdominal pain, bowel urgency, fecal incontinence, and sleep interruption
Risankizumab led to earlier and sustained improvements in individual symptoms—including abdominal pain, bowel urgency, fecal incontinence, and sleep interruption
Risankizumab led to earlier and...
09/04/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Guselkumab Demonstrates Efficacy and Safety in Moderate-to-Severe Crohn’s Disease
09/04/2025
Jessica Garlewicz
The study met all primary and multiplicity-controlled secondary endpoints, including clinical and endoscopic outcomes through 48 weeks.
The study met all primary and multiplicity-controlled secondary endpoints, including clinical and endoscopic outcomes through 48 weeks.
The study met all primary and...
09/04/2025
Advances in Inflammatory Bowel Disease Network
News
Validation of a Simple Ultrasound Score for Crohn’s Disease
08/28/2025
Rebecca Mashaw
A multicenter study confirms the accuracy and reliability of a simplified ultrasound score for assessing Crohn’s disease activity.
A multicenter study confirms the accuracy and reliability of a simplified ultrasound score for assessing Crohn’s disease activity.
A multicenter study confirms the...
08/28/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Real-World Effectiveness and Safety of Risankizumab in Crohn’s Disease
08/21/2025
Rebecca Mashaw
Risankizumab demonstrates sustained clinical benefit and favorable safety in Crohn’s disease, including among ustekinumab-experienced patients.
Risankizumab demonstrates sustained clinical benefit and favorable safety in Crohn’s disease, including among ustekinumab-experienced patients.
Risankizumab demonstrates...
08/21/2025
Advances in Inflammatory Bowel Disease Network
Research Highlights
Intestinal Ultrasound Activity in Pregnancy Predicts Adverse Outcomes in Women With Inflammatory Bowel Disease
08/21/2025
Rebecca Mashaw
Intestinal ultrasound during pregnancy may more reliably predict adverse maternal and neonatal outcomes from inflammatory bowel disease than clinical or biochemical assessments alone, recent research revealed.
Intestinal ultrasound during pregnancy may more reliably predict adverse maternal and neonatal outcomes from inflammatory bowel disease than clinical or biochemical assessments alone, recent research revealed.
Intestinal ultrasound during...
08/21/2025
Advances in Inflammatory Bowel Disease Network

Latest Podcasts

IBD Drive time logo
Podcast
Anita Afzali, MD, on the ACG Guidelines for Crohn's Disease
08/18/2025
Raymond Cross, MD; Anita Afzali
Dr Anita Afzali reviews with Dr Raymond Cross the updated guidelines for managing Crohn's disease from the American College of Gastroenterology,
Dr Anita Afzali reviews with Dr Raymond Cross the updated guidelines for managing Crohn's disease from the American College of Gastroenterology,
Dr Anita Afzali reviews with Dr...
08/18/2025
Advances in Inflammatory Bowel Disease Network
IBD logo
Podcast
IBD Drive Time: Importance of Diet in the Management of Crohn's Disease
05/25/2023
Raymond Cross, MD; James D. Lewis
In the third episode of IBD Drive Time, host Raymond Cross, MD, discusses research into how diet can alleviate symptoms—or worsen disease—among patients with Crohn's disease with Dr James Lewis, who conducted the DINE-CD study.
In the third episode of IBD Drive Time, host Raymond Cross, MD, discusses research into how diet can alleviate symptoms—or worsen disease—among patients with Crohn's disease with Dr James Lewis, who conducted the DINE-CD study.
In the third episode of IBD...
05/25/2023
Advances in Inflammatory Bowel Disease Network
Saurabh Mehandru
Podcast
Saurabh Mehandru, MD, on Durability of Response to p19 Inhibitors in IBD
03/24/2023
Dr. Mehandru reviews the results of 3 pivotal clinical trials on p19 inhibitors where the drug effect was found to be sustained for an extended period following drug withdrawal.
Dr. Mehandru reviews the results of 3 pivotal clinical trials on p19 inhibitors where the drug effect was found to be sustained for an extended period following drug withdrawal.
Dr. Mehandru reviews the results...
03/24/2023
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Sara Horst, MD, on Risankizumab for Crohn Disease
07/12/2022
In this episode of IBD Drive Time, hosts Raymond Cross, MD, and Millie Long, MD, talk to Dr Sara Horst of Vanderbilt University about the newly approved IL-23 inhibitor, risankizumab, and its benefit in treating inflammatory bowel disease.
In this episode of IBD Drive Time, hosts Raymond Cross, MD, and Millie Long, MD, talk to Dr Sara Horst of Vanderbilt University about the newly approved IL-23 inhibitor, risankizumab, and its benefit in treating inflammatory bowel disease.
In this episode of IBD Drive...
07/12/2022
Advances in Inflammatory Bowel Disease Network
Phillip Fleshner
Podcast
Phillip Fleshner, MD, on Perianal/Fistulizing Crohn's Disease
04/30/2022
In this podcast, Dr Phillip Fleshner, director of colorectal surgery at Cedars-Sinai Medical Center in Los Angeles, discusses the complexities of medical and surgical treatment of perianal and fistulizing Crohn disease, which he spoke about...
In this podcast, Dr Phillip Fleshner, director of colorectal surgery at Cedars-Sinai Medical Center in Los Angeles, discusses the complexities of medical and surgical treatment of perianal and fistulizing Crohn disease, which he spoke about...
In this podcast, Dr Phillip...
04/30/2022
Advances in Inflammatory Bowel Disease Network
David Schwartz, MD
Podcasts
David Schwartz, MD, on the ENTERPRISE Study of Vedolizumab for Perianal Crohn Disease
12/30/2021
In this podcast, Dr Schwartz, from Vanderbilt University, discusses the ENTERPRISE multinational program that examined the efficacy and safety of vedolizumab for perianal Crohn’s disease.
In this podcast, Dr Schwartz, from Vanderbilt University, discusses the ENTERPRISE multinational program that examined the efficacy and safety of vedolizumab for perianal Crohn’s disease.
In this podcast, Dr Schwartz,...
12/30/2021
Advances in Inflammatory Bowel Disease Network
Adam Cheifetz
Podcast
Adam Cheifetz, MD, and Konstantinos Papamichail, MD, on Therapeutic Drug Monitoring in Fistulizing Crohn Disease
09/03/2021
In this podcast, Adam Cheifetz, MD, director of the Center for Inflammatory Bowel Disease at Beth Israel Deaconess Medical Center and associate professor at Harvard Medical School, and Konstantinos Papamichail, M.D., Ph.D., instructor in...
In this podcast, Adam Cheifetz, MD, director of the Center for Inflammatory Bowel Disease at Beth Israel Deaconess Medical Center and associate professor at Harvard Medical School, and Konstantinos Papamichail, M.D., Ph.D., instructor in...
In this podcast, Adam Cheifetz,...
09/03/2021
Advances in Inflammatory Bowel Disease Network
Sara Horst, MD, and David Schwartz, MD, on Current and Upcoming Treatments for Perianal Crohn Disease
Podcasts
Sara Horst, MD, and David Schwartz, MD, on Current and Upcoming Treatments for Perianal Crohn Disease
05/07/2021
In this podcast, Drs Sara Horst and David Schwartz of Vanderbilt University wrap up their podcast series on perinanal Crohn disease with a discussion of existing and upcoming therapies and procedures.
In this podcast, Drs Sara Horst and David Schwartz of Vanderbilt University wrap up their podcast series on perinanal Crohn disease with a discussion of existing and upcoming therapies and procedures.
In this podcast, Drs Sara Horst...
05/07/2021
Advances in Inflammatory Bowel Disease Network
Sara Horst, MD, and David Schwartz, MD, on Refractory Perianal Crohn's Disease
Podcasts
Sara Horst, MD, and David Schwartz, MD, on Refractory Perianal Crohn's Disease
04/26/2021
Drs Sara Horst and David Schwartz from Vanderbilt University continue their podcast series on Crohn disease in this discussion about the challenges of treating the patient with refractory Crohn disease and their approach to controlling the...
Drs Sara Horst and David Schwartz from Vanderbilt University continue their podcast series on Crohn disease in this discussion about the challenges of treating the patient with refractory Crohn disease and their approach to controlling the...
Drs Sara Horst and David...
04/26/2021
Advances in Inflammatory Bowel Disease Network
Sara Horst, MD and David Schwartz, MD, on Surgery and Therapies for Perianal Crohn Disease
Podcasts
Sara Horst, MD and David Schwartz, MD, on Surgery and Therapies for Perianal Crohn Disease
04/08/2021
In this second podcast of a series on the care of patients with perianal Crohn disease, Dr Horst and Dr Schwartz, both from Vanderbilt University, discuss when to involve a surgeon and the preferred medical therapies used to treat this...
In this second podcast of a series on the care of patients with perianal Crohn disease, Dr Horst and Dr Schwartz, both from Vanderbilt University, discuss when to involve a surgeon and the preferred medical therapies used to treat this...
In this second podcast of a...
04/08/2021
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Jason Schairer, MD, on Extraintestinal Manifestations in IBD
09/25/2025
Jason Schairer, MD; Raymond Cross, MD
Host Raymond Cross, MD, and guest Dr Jason Schairer discuss the varieties of extraintestinal manifestations that may be seen in patients with IBD, how to diagnose them and when to rely on colleagues in dermatology, ophthalmology, and...
Host Raymond Cross, MD, and guest Dr Jason Schairer discuss the varieties of extraintestinal manifestations that may be seen in patients with IBD, how to diagnose them and when to rely on colleagues in dermatology, ophthalmology, and...
Host Raymond Cross, MD, and...
09/25/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
Ryan Ungaro, MD, on Perturbances in Metabolic Pathways in IBD
09/02/2025
Raymond Cross, MD; Ryan Ungaro
Dr Raymond Cross discusses with Dr Ryan Ungaro how the Mount Sinai Crohn's and Colitis Registry, a prospective observational cohort, is being studied to determine if its detailed clinical information and omics data collected can identify new...
Dr Raymond Cross discusses with Dr Ryan Ungaro how the Mount Sinai Crohn's and Colitis Registry, a prospective observational cohort, is being studied to determine if its detailed clinical information and omics data collected can identify new...
Dr Raymond Cross discusses with...
09/02/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
Anita Afzali, MD, on the ACG Guidelines for Crohn's Disease
08/18/2025
Raymond Cross, MD; Anita Afzali
Dr Anita Afzali reviews with Dr Raymond Cross the updated guidelines for managing Crohn's disease from the American College of Gastroenterology,
Dr Anita Afzali reviews with Dr Raymond Cross the updated guidelines for managing Crohn's disease from the American College of Gastroenterology,
Dr Anita Afzali reviews with Dr...
08/18/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: David Rubin, MD, on the ACG Guidelines for Ulcerative Colitis
08/04/2025
David T. Rubin, MD; Raymond Cross, MD
Host Raymond Cross, MD, discusses the updates in the American College of Gastroenterology guideline on managing ulcerative colitis with first author David Rubin, MD.
Host Raymond Cross, MD, discusses the updates in the American College of Gastroenterology guideline on managing ulcerative colitis with first author David Rubin, MD.
Host Raymond Cross, MD,...
08/04/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Corey Siegel, MD, on Defining Quality Care for IBD
07/15/2025
Raymond Cross, MD; Corey A. Siegel, MD, MS
Host Raymond Cross, MD, and Dr Corey Siegel delve into the factors that constitute quality care for patients with IBD today, and how the definition of quality care has evolved over time.
Host Raymond Cross, MD, and Dr Corey Siegel delve into the factors that constitute quality care for patients with IBD today, and how the definition of quality care has evolved over time.
Host Raymond Cross, MD, and Dr...
07/15/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Dr Susan Kais on Pregnancy and IBD
06/19/2025
Raymond Cross, MD
Drs Raymond Cross and Susan Kais delve into the issues surrounding fertility, pregnancy, postpartum care and more for women with IBD.
Drs Raymond Cross and Susan Kais delve into the issues surrounding fertility, pregnancy, postpartum care and more for women with IBD.
Drs Raymond Cross and Susan Kais...
06/19/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
Drs Sara Horst and Jordan Axelrad Review Studies on Infection, Malignancy With IBD Therapies
06/06/2025
Sara Horst, MD; Jordan Axelrad
Guest host Sara Horst, MD, talks with Dr Jordan Axelrad about two studies on safety of advanced therapies for inflammatory bowel disease, including risks of infection and malignancy.
Guest host Sara Horst, MD, talks with Dr Jordan Axelrad about two studies on safety of advanced therapies for inflammatory bowel disease, including risks of infection and malignancy.
Guest host Sara Horst, MD, talks...
06/06/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Miguel Regueiro, MD, on Providing Multidisciplinary Care in IBD
05/21/2025
Miguel D. Regueiro, MD; Raymond Cross, MD
Dr Regueiro and IBD Drive Time host Raymond Cross, MD, discuss the importance and the challenges of providing multidisciplinary care to patients with IBD, including dietary guidance, mental health services, and more.
Dr Regueiro and IBD Drive Time host Raymond Cross, MD, discuss the importance and the challenges of providing multidisciplinary care to patients with IBD, including dietary guidance, mental health services, and more.
Dr Regueiro and IBD Drive Time...
05/21/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
Edward Barnes, MD, on Antibiotics and Risk of Pouchitis
05/20/2025
Edward L. Barnes; Sara Horst, MD
Guest host Sara Horst, MD, talks with Dr Ed Barnes about his research into whether antibiotics taken a year before an IPAA may contribute to the development of pouchitis.
Guest host Sara Horst, MD, talks with Dr Ed Barnes about his research into whether antibiotics taken a year before an IPAA may contribute to the development of pouchitis.
Guest host Sara Horst, MD, talks...
05/20/2025
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Edward Barnes, MD, on Pouch Complications
05/09/2025
Guest host Sara Horst, MD, and Dr Edward Barnes discuss complications of ileal pouch-anal anastamosis surgery and whether recent use of antibiotics puts patients at risk of pouchitis.
Guest host Sara Horst, MD, and Dr Edward Barnes discuss complications of ileal pouch-anal anastamosis surgery and whether recent use of antibiotics puts patients at risk of pouchitis.
Guest host Sara Horst, MD, and...
05/09/2025
Advances in Inflammatory Bowel Disease Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use